Uncategorized

Investment proceeds will support commercialization of the company’s breakthrough biologics manufacturing technology Univercells SA (‘Univercells’) and Global Health Investment Fund (‘GHIF’) are pleased to announce the closing of a €16 million ($18.8 million) Series B equity financing. Investment proceeds will support the continued development of Univercells’ game-changing biomanufacturing technology, which has the potential to dramatically [...]

  Themis Raises EUR 10 Million in Series C Financing to Advance Clinical Pipeline Proceeds will support the further development of the company's chikungunya vaccine candidate VIENNA - January 4, 2018 - Themis announced today the close of a Series C financing round totaling EUR 10 million. Global Health Investment Fund (GHIF), a New York-based impact investment firm focused [...]

  Independent Review of GHIF Suggests the Fund is Performing Against Original Impact Investment Objectives Innovative financing model shows promise for supporting global health research and development in a sustainable manner FRANKFURT - December 21, 2016 - In mid-2016, KfW Development Bank, an anchor investor in GHIF, commissioned an independent mid-term review of the fund's performance [...]

Press Release ### Global Health Investment Fund Managing Partner Curt LaBelle Speaks at Priority Review Voucher Summit Panel presentation covers PRV program’s impact on neglected disease research   NEW YORK - November 3, 2016 - Curt LaBelle, MD, Managing Partner of the Global Health Investment Fund, led a panel discussion yesterday on the impact of [...]

Press Release ### Global Health Investment Fund Purchases $8 Million of Convertible Notes Issued by Access Bio, Inc. Proceeds will finance the purchase and installation of new manufacturing equipment for Access Bio’s rapid diagnostic test products   NEW YORK--The Global Health Investment Fund (“GHIF”) is pleased to announce that it has invested $8 million in [...]

Press Release ### Atomo Secures $6 Million from the Global Health Investment Fund The investment will support scale up of Atomo’s global health activities, focusing on continued rollout of its award winning AtomoRapid™ HIV test and launch of an affordable HIV self-test offering unmatched performance January 13, 2016 (SYDNEY and NEW YORK): The Global Health [...]

From the World Health Organization:   Cholera vaccine supply set to double, easing global shortage 8 January 2016 Globally, OCV production is low, with demands currently exceeding supply. Sudan and Haiti last year made requests to WHO for supplies of vaccines to conduct pre-emptive vaccination campaigns that could not be filled because of the global [...]

$10 Million Investment into the Registration of Moxidectin, an Important New Global Health Medicine for River Blindness If approved, moxidectin is expected to significantly accelerate the eradication of this terrible neglected disease March 8, 2015 (LONDON – UK): The Global Health Investment Fund (GHIF) and Medicines Development for Global Health (Medicines Development) announced today a [...]

  Global Health Investment Fund Announcement of Collaborative Funding Agreement with Epistem PLC Investment will support the roll-out of Epistem's Genedrive® molecular diagnostic platform as the company's tuberculosis assay enters pivotal field trials in key developing world locations July 22, 2014 (LONDON): The Global Health Investment Fund I, LLC (GHIF), is pleased to announce today that it [...]